FRANKLIN TWP., N.J. - Firefighters continue to battle a building fire on Edison Road in Franklin Township, Warren County. It started Tuesday night. Around 600 bales of hay were stored here by a farmer ...

Nancy Yvonne Detrick was born on November 19, 1951 in Garberville and died on October 10, 2025 at her home in Wool Mountain surrounded by family. Nancy heroically lost her battle to cancer after a ...

GE Aerospace is funding a new workforce training program for military veterans outside Fort Bragg, helping those who want to work in the aerospace industry as civilian technicians. North Carolina is ...

CHENGDU, China, Oct. 18, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in ...

Something unusual is happening to biotech stocks: They’re going up. A drug-pricing deal between Pfizer and the White House and a spate of deals have sent the SPDR S&P Biotech exchange-traded fund up 9 ...

LONDON, Oct 15 (Reuters) - German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 million) in its biggest financing round to date, contributing to a total of 495 million ...

Shares of Sana Biotechnology (NASDAQ:SANA) climbed ~24% in the morning hours on Wednesday, triggering several trading halts after Canadian hedge fund manager Eric Jackson said that he is long the ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

Oct 14 (Reuters) - U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical (4502.T), opens new tab, deepening their ...

Diagnostic play Nexsen surges 47% on its ASX debut, after a well-supported raising Audeara has entered the Japanese market, we hear FDA drug approvals plunge Shares in our latest ASX biotech entrant ...